<i>In Vitro</i> Activity of the Siderophore Cephalosporin, Cefiderocol, against a Recent Collection of Clinically Relevant Gram-Negative Bacilli from North America and Europe, Including Carbapenem-Nonsusceptible Isolates (SIDERO-WT-2014 Study)
Meredith Hackel, Daniel F. Sahm(Allegheny College), Yoshinori Yamano(Shionogi (Japan)), James A. Karlowsky(University of Manitoba), Masakatsu Tsuji(Shionogi (Japan)), Roger Echols
Cited by 196
Related Papers
Prevalence in the United States of <i>aac(6</i> ′ <i>)</i> - <i>Ib</i> - <i>cr</i> Encoding a Ciprofloxacin-Modifying Enzyme
|Antimicrobial Agents and Chemotherapy|2006|749
Multiple-Drug Resistant Enterococci: The Nature of the Problem and an Agenda for the Future
|Emerging infectious diseases|1998|732
Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States
|Annals of Clinical Microbiology and Antimicrobials|2006|384
Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of <i>Escherichia coli</i> from Female Outpatients in the United States
|Antimicrobial Agents and Chemotherapy|2002|369
Antimicrobial Resistance Among Uropathogens that Cause Community‐Acquired Urinary Tract Infections in Women: A Nationwide Analysis
|Clinical Infectious Diseases|2001|361